Transgenic mice expressing HBZ under the control of the granzyme B promoter (Gzmb-HBZ) develop lymphoproliferative diseases such as tumors, splenomegaly, abnormal white blood cell numbers, and hypercalcemia [56]. This evidence concerns the gene GZMB and Hypercalcemia.